These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19657206)

  • 41. [Effect of an acidic sulfated polysaccharide on whole blood coagulability. In vivo study in rats].
    Caporiccio B; Braun M; Vignaud M; Chalet M; Codomier L; Teste J; Catayée G
    C R Seances Soc Biol Fil; 1984; 178(6):691-6. PubMed ID: 6242035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [When NSAIDs, when homeopathic remedies?].
    Schneider C
    MMW Fortschr Med; 2006 Jun; 148(25):56. PubMed ID: 16859167
    [No Abstract]   [Full Text] [Related]  

  • 43. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ; Segal HC; Yacoub M
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract]   [Full Text] [Related]  

  • 44. Pretreatment with thyroxin 10(-8) and the effect of homeopathically prepared thyroxin 10(-30) on highland frogs--a multi-researcher study.
    Welles SU; Endler PC; Scherer-Pongratz W; Suanjak-Traidl E; Weber S; Spranger H; Frass M; Lothaller H
    Forsch Komplementmed; 2007 Dec; 14(6):353-7. PubMed ID: 18219210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.
    Bode V; Welzel D; Franz G; Polensky U
    Arch Intern Med; 1990 Oct; 150(10):2117-9. PubMed ID: 2121114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis on the therapeutic effect of combined use of acupuncture and mediation in 297 cases of male sterility.
    Zheng Z
    J Tradit Chin Med; 1997 Sep; 17(3):190-3. PubMed ID: 10437193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary intervention.
    Lawrence M; Mixon TA; Cross D; Gantt DS; Dehmer GJ
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):52-5. PubMed ID: 14696159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coagulant and anticoagulant action of Vipera berus venom on human blood].
    Bruno C; Cuppini R
    Boll Soc Ital Biol Sper; 1981 May; 57(9):1037-41. PubMed ID: 7284120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drop-out rates of cancer patients participating in longitudinal RCTs.
    Mathibe LJ
    Contemp Clin Trials; 2007 Jul; 28(4):340-2. PubMed ID: 17449332
    [No Abstract]   [Full Text] [Related]  

  • 51. [Can systemic changes in the blood coagulation system be detected in low-dose local thrombolysis with r-tPA?].
    Weichenhain B; Stiegler H; Spengel F; Standl E; Woitinas F; Roth R; Schulz K; Mehnert H
    Vasa Suppl; 1991; 32():314-7. PubMed ID: 1771523
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing risk of bias in randomized controlled trials.
    Purgato M; Barbui C; Cipriani A
    Epidemiol Psichiatr Soc; 2010; 19(4):296-7. PubMed ID: 21322502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metals in air pollution particles decrease whole-blood coagulation time.
    Sangani RG; Soukup JM; Ghio AJ
    Inhal Toxicol; 2010 Jul; 22(8):621-6. PubMed ID: 20388004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of adverse reactions to injections of Chinese materia medica.
    Bian Z; Shang H; Cheng C; Wu T; Li Y; Zhang B
    J Evid Based Med; 2010 May; 3(2):88-94. PubMed ID: 21349050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thrombelastographic studies made to objectify the effects of Grisaldon upon the process of coagulation (author's transl)].
    Fröhlich M
    Zahn Mund Kieferheilkd Zentralbl; 1979; 67(6):579-82. PubMed ID: 160158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Healthy transitions--pregnancy to motherhood with homeopathic medicine.
    Martin P
    Midwifery Today Int Midwife; 2008; (88):42-3. PubMed ID: 19244785
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.